Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,772,803
+$414,796 QoQ
Shares Held
7,045
+12.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#2,061
of 4,153 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kathmere Capital Management, LLC holds $38,480,404 across 14 Drug Manufacturers - General names. ABBV ranks #7 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
46,204 | $11,734,429 | |
| 2 | LLY |
ELI LILLY & Co
|
4,626 | $5,548,563 | |
| 3 | MRK |
Merck & Co., Inc.
|
30,944 | $3,976,304 | |
| 4 | NVS |
Novartis AG
|
22,990 | $3,602,992 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
26,787 | $3,384,269 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
37,197 | $2,143,291 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
7,045 | $1,772,803 | |
| 8 | BIIB |
Biogen Inc.
|
7,285 | $1,573,997 |
All Filings in ABBV
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,772,803 | 7,045 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,358,007 | 6,244 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,009,240 | 4,417 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $941,441 | 4,066 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $633,892 | 3,415 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $696,444 | 3,324 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $514,619 | 2,896 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $492,910 | 2,496 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $295,185 | 1,721 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $413,184 | 2,269 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $340,624 | 2,198 | Shares | Sole | 2024-04-16 | |
| 2023-09-30 | $447,030 | 2,999 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $351,241 | 2,607 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $576,600 | 3,618 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $493,718 | 3,055 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $304,790 | 2,271 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $339,402 | 2,216 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $348,698 | 2,151 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $225,170 | 1,663 | Shares | Sole | 2022-01-27 | |
| 2020-12-31 | $151,188 | 1,411 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $106,071 | 1,211 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||